methamphetamine has been researched along with afimoxifene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HH; Cherng, CG; Hsu, CH; Kuo, Y; Yu, L | 1 |
| Chen, HH; Cherng, CG; Chuang, KP; Kuo, YM; Shieh, CC; Yu, L | 1 |
2 other study(ies) available for methamphetamine and afimoxifene
| Article | Year |
|---|---|
Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum.
Topics: Aging; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Male; Methamphetamine; Mice; Neurotoxins; Ovariectomy; Progesterone; Tamoxifen | 2002 |
4-Hydroxytamoxifen attenuates methamphetamine-induced nigrostriatal dopaminergic toxicity in intact and gonadetomized mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Body Temperature; Castration; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Estrogen Antagonists; Female; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neurotoxins; Sex Factors; Superoxide Dismutase; Tamoxifen; Time Factors; Xanthine Oxidase | 2003 |